The Daily Papule

Meeting abstracts

AAD 2026

American Academy of Dermatology · Denver, 27–31 March 2026

1,877 abstracts, published in JAAD on 6 July 2026. Their text is on the JAAD website.

  1. 70655

    Safety and Efficacy of Janus Kinase Inhibitors for Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis

    Fonseca LO, Vieira TF, … senior author Kimball A

  2. 71184

    Biologic treatment in Psoriasis and Hidradenitis Suppurativa patients with active malignancy: Experience from a Tertiary Care Hospital

    Carrera Hernandez MJ, Martinez Lorenzo ER, … senior author Gomez Dorado BA

  3. 71226

    Indirect Comparisons of Janus Kinase Inhibitors and Biologic Immunotherapies for Hidradenitis Suppurativa: Results from an Updated Systematic Review and Network Meta-analysis

    Burla MM, Chater RC, … senior author Haber R

  4. 71352

    Efficacy of izokibep, a novel interleukin-17A inhibitor, in moderate to severe hidradenitis suppurativa: Week 32 results from a randomized, double-blind, placebo-controlled, multicenter, phase 3 study

    Papp KA, Bechara FG, … senior author Kimball AB

  5. 71660

    GLP-1 Receptor Agonist Use in Patients with Psoriasis or Hidradenitis Suppurativa

    Granovsky R, Bai A, … senior author Cobos G

  6. 71951

    Comparative Efficacy and Safety of Janus Kinase Inhibitors for Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis

    Shams Ul Arifeen KM, Rasheed T, … senior author Qureshy A

  7. 71987

    Characterizing inpatient hospitalizations for hidradenitis suppurativa and assessing the impact of outpatient dermatology care on hospitalizations

    Rau A, Ziglar J, … senior author Hamzavi I

  8. 72227

    Preexisting Psychiatric Disease Is Associated With Increased Five-Year Incidence of Adverse Clinical Outcomes in Adults With Hidradenitis Suppurativa: A Retrospective Cohort Study of 44,550 Patients

    Kaltchenko M, Chien A

  9. 72271

    Utility of Artificial Intelligence Platforms for Patient-Generated Questions in Hidradenitis Suppurativa: A Multi-National, Blinded Expert Panel Evaluation

    Cho SW, Aora E, … senior author Tolkachjov S

  10. 72433

    Characterization of the IHS4 Response to Lutikizumab Treatment in Biologic-Naïve Patients With Moderate-to-Severe Hidradenitis Suppurativa (HS)

    Alhusayen R, Zouboulis CC, … senior author Kimball AB

  11. 72512

    Hidradenitis Suppurativa and Hormonal Therapies in Transgender Individuals

    Katamanin O, Tan I, … senior author Flood K

  12. 72543

    Hidradenitis Suppurativa: Successful Management with Staged Carbon Dioxide Laser Marsupialization

    Resnik S, Gomez-Lara A, … senior author Hazen P

  13. 72625

    Stage 1: Dermatologic Continuity of Care in Hidradenitis Suppurativa: A Retrospective Review of Emergency Department and Inpatient Presentations at a Los Angeles Safety-Net Hospital

    Noveron MS, Conde G, … senior author Smogorzewski J

  14. 72748

    Maternal and Perinatal Outcomes in Pregnant Women with Hidradenitis Suppurativa: Systematic Review and Meta-Analysis

    Mesquita Cunha AB, Milanesi GS, … senior author Loda GA

  15. 73044

    Combination Biologic Therapy in Severe, Refractory Hidradenitis Suppurativa: Safety and Early Clinical Outcomes

    Bastian E, Naik H

  16. 73167

    The Financial Burdens of Wound Care in Hidradenitis Suppurativa: A Cross-Sectional Study

    Farah M, Zarabian N, … senior author Friedman A

  17. 73230

    Bimekizumab efficacy by patient subgroups in moderate to severe hidradenitis suppurativa: 3-year phase 3 results from BE HEARD EXT

    Sayed CJ, Porter ML, … senior author Kokolakis G

  18. 73335

    Adverse Pregnancy Outcomes in Women with Hidradenitis Suppurativa: Systematic Review and Meta-Analysis

    Matos de Albuquerque K, Visentini LM, … senior author Barros de Deus Nunes Junior E

  19. 73363

    Dermoscopy criteria of Hidradenitis suppurativa in comparison to healthy controls

    Hobelsberger S, Wirth S, Beissert S

  20. 73400

    Bimekizumab in Hidradenitis Suppurativa: Insights from Real-World Clinical Practice

    González LA, Romero IV, … senior author Barrios ML

  21. 73493

    Bimekizumab leads to sustained flare-free status in moderate to severe hidradenitis suppurativa: 3-year data from BE HEARD EXT

    Daveluy S, Naik HB, … senior author Martorell A

  22. 73498

    Bimekizumab efficacy by disease duration and severity in moderate to severe hidradenitis suppurativa: 3-year phase 3 results from BE HEARD EXT

    Chovatiya R, Alavi A, … senior author Sabat R

  23. 73536

    Psoriasis and Hidradenitis Suppurativa Are Associated With Increased Risk of Cutaneous Squamous Cell Carcinoma

    Yan M, Yang CY, … senior author DeWane M

  24. 73586

    Evaluating Temporal Trends in Hidradenitis Suppurativa Demographics and Post-Operative Outcomes: A Review of Evolving Disease Management, 2011-2023

    Ahlers K, Rajaee L, … senior author Abraham G

  25. 73779

    Prospective Evaluation of Patient-Reported Disease Flare in Hidradenitis Suppurativa

    Tsopurashvili E, de Oliveira Wafae BG, … senior author Porter ML

  26. 73908

    Clinical Efficacy of Golimumab for Treatment-Refractory Hidradenitis Suppurativa

    Sage M, Sayed C

  27. 73932

    Patient perceptions of laser hair removal for treatment of hidradenitis suppurativa

    Yang L, Bosch L, Riley J

  28. 73956

    An In Silico Investigation of the Laminin Gene Family in the Genetic Architecture of Hidradenitis Suppurativa A Meta-Analysis of Over 1.15 Million Individuals Finds No Evidence of Association Between Common Variants in the Laminin Gene Family and Hidraden

    Certuche H, Kay K, Kroger K

  29. 73973

    Tertiary Center Inpatient Hidradenitis Suppurativa Care: Opportunities for Outpatient Pathways

    Ahmad A, Kole A, Lafeir M

  30. 73985

    Association of GLP-1 Therapy with Reduced Biologic Initiation in Hidradenitis Suppurativa: A Retrospective Cohort Study

    Kasheri E, Smith J

  31. 74007

    Do biologics lower the risk of depression and anxiety in hidradenitis suppurativa?

    Patel J, Haque S, Patel T

  32. 74087

    Educational Gaps in Wound Care for Hidradenitis Suppurativa: Insights From a Patient Experience Survey

    Vidal SI, Farah M, … senior author Friedman A

  33. 74118

    Standardized Scoring vs. Real-World Assessment: Challenges in Capturing Hidradenitis Suppurativa Severity

    Wafae BGO, Tehrani MD, … senior author Kimball AB

  34. 74121

    Associations of Ambient Temperature, Humidity, PM2.5, PM 10, and Carbon Monoxide with Healthcare Visit Rates for Hidradenitis Suppurativa: A Retrospective Observational Study

    Grinde G, Lorenz M, … senior author Wei E

  35. 74244

    High and Ultra-High-Frequency Ultrasound for the Diagnosis and Management of Hidradenitis Suppurativa: A Systematic Review

    Putini Vieira AC, Andrade Lima RP, … senior author Farias de Vasconcelos RC

  36. 74395

    Battlefield Acupuncture to Treat Pain in Hidradenitis Suppurativa

    TABATABAEI E, Zhan X, Daveluy S

  37. 74401

    Confidence vs. Correctness: Evaluating the Impact of Myth-Busting Education on Hidradenitis Suppurativa Beliefs

    TABATABAEI E, Benitez C, Daveluy S

  38. 74469

    Real-world treatment journey and unmet needs of people with hidradenitis suppurativa: Insights from social media research in China

    Ingram JR, Wu W, … senior author Garg A

  39. 74494

    Designing a secukinumab dosing regimen in adolescents with moderate to severe hidradenitis suppurativa using model-informed drug development

    Bieth B, Renard D, … senior author Mendelson M

  40. 74546

    Increased Interest Trends of Hidradenitis Suppurativa Based on Sociodemographic Backgrounds of States

    Brauer S, Nigro A, … senior author Handler M

  41. 74547

    Impact of Metabolic Risk and Healthcare Access on GLP-1RA Counseling and Prescribing in Psoriasis and Hidradenitis Suppurativa

    Granovsky R, Bai A, … senior author Cobos G

  42. 74566

    Assessing the Economic and Financial Burden of Living with Hidradenitis Suppurativa

    Frasier K, Ingraham N, … senior author Garg A

  43. 74567

    Peripheral memory T cells with skin-homing receptors as biomarkers in atopic dermatitis and hidradenitis suppurative

    Jiménez-Sánchez A, Olivares-Guerrero M, … senior author Fuente HDL

  44. 74594

    Use of a 1726-nm Laser in Early Hidradenitis Suppurativa: Preliminary Clinical, Ultrasound, and Histologic Findings from a Pilot Study

    Beraja G, Beraja G, … senior author Eber A

  45. 74633

    Perioperative Range of Motion Limitations in Hidradenitis Suppurativa: A Review of Functional Outcomes and Rehabilitation Approaches

    Silberzweig A, Velaoras A, … senior author Ahmed S

  46. 74634

    Increasing Hidradenitis Suppurativa Prevalence Over Time: Pooled Estimates Across Multiple United States National Claims Databases, 2018 to 2024

    Garg A, Ingram JR, … senior author Ye Y

  47. 74650

    Consensus Study on the Best Practices of Laser Hair Reduction for Hidradenitis Suppurativa

    Mallela T, Wadhera A, … senior author Sayed C

  48. 74826

    A Retrospective Analysis of GLP-1 Inhibitors in the Management of Hidradenitis Suppurativa

    Khan F, Ede N, … senior author Pena-Robichaux V

  49. 74889

    Biologics Significantly Reduce Incision and Drainage Procedures in Hidradenitis Suppurativa

    Carstens LY, Herrera H, Bordeaux J

  50. 75004

    Hidradenitis Suppurativa Hospitalizations in the United States: National trends, Comorbidities, Procedures, and Mortality based on an analysis of the National Inpatient Sample

    Razi S, Kuo YH, … senior author Rao B